Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence.
Recent preclinical studies suggest that THC-containing cannabis extracts have limited effectiveness and are associated with side effects. Therefore, it is important to focus on targeting channels and receptors other than cannabinoid CB1 receptors to improve the treatment of chronic neuropathic pain.
- Sokolaj E et al (2023).
- J Neurochem.
- DOI:
- 10.1111/jnc.15964
- PubMed:
- 37747128